GILOTRIF vs VINORELBINE TARTRATE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. GILOTRIF and VINORELBINE TARTRATE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	GILOTRIF	VINORELBINE TARTRATE
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	AFATINIB DIMALEATE	VINORELBINE TARTRATE
Manufacturer	Boehringer Ingelheim	Rising
Dosage forms	Tablet	Injectable
Drug class	—	Vinca Alkaloid
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma	Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Hodgkin Disease

gilotrif vinorelbine tartrate

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

AFATINIB DIMALEATE

VINORELBINE TARTRATE

Manufacturer

Boehringer Ingelheim

Rising

Dosage forms

Tablet

Injectable

Drug class

—

Vinca Alkaloid

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma

Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Hodgkin Disease

Frequently asked questions

Which is better-rated, Gilotrif or Vinorelbine Tartrate?

Gilotrif and Vinorelbine Tartrate are tied at 3.6 out of 5 by our independent rating.

What is the difference between Gilotrif and Vinorelbine Tartrate?

Gilotrif contains Afatinib Dimaleate, while Vinorelbine Tartrate contains Vinorelbine Tartrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.